Ligand Pharmaceuticals
LGND
LGND
203 hedge funds and large institutions have $1.95B invested in Ligand Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 89 increasing their positions, 68 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
30% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 37
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Holders
203
Holding in Top 10
2
Calls
$10.5M
Puts
$5.41M
Top Buyers
| 1 | +$40.6M | |
| 2 | +$33.9M | |
| 3 | +$7.86M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.15M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$6.61M |
Top Sellers
| 1 | -$114M | |
| 2 | -$14.5M | |
| 3 | -$10.8M | |
| 4 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$8.23M |
| 5 |
Morgan Stanley
New York
|
-$4.82M |